Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies

被引:6
作者
Daniel, D
Opelz, G
Mulder, A
Kleist, C
Süsal, C
机构
[1] Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, D-69120 Heidelberg, Germany
[2] Leiden Univ, Med Ctr, Dept Immunohaematol & Bloodtransfus, Leiden, Netherlands
关键词
anti-HLA antibodies; apoptosis; DNA fragmentation; AIF; caspases;
D O I
10.1016/j.humimm.2003.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We demonstrated recently that human leukocyte antigen (HLA) class I human monoclonal antibodies (mAbs) are able to induce apoptosis of resting human lymphocytes as well as Jurkat lymphoblastic T cells. We now analyzed the signaling pathway involved in apoptosis mediated by human HLA class I allele-specific mAb OK2F3 and mouse monomorphic mAb W6/32. An inhibitor of a broad spectrum of caspases had only a moderate inhibiting effect, and an inhibitor of caspase 3 failed to inhibit HLA class I-mediated apoptosis. Although caspase 3 activation was not observed, internucleosomal DNA fragmentation was found in half of the apoptotic cells. Importantly, the mitochondrio-nuclear redistribution of apoptosis inducing factor (AIF), a caspase-independent mitochondrial death effector, was detected after I hour of treatment with human anti-HLA mAb and was associated with large-scale DNA fragmentation, whereas the release of cytochrome c, which is responsible for caspase-dependent internucleosomal fragmentation, followed AIF translocation and occurred after 2 hours. Our results indicate that apoptosis mediated through HLA class I molecules represents a unique mechanism of cell death in Jurkat T lymphoblasts that involves two parallel pathways, one caspase-independent and the other caspase-dependent. This study clarifies the precise mechanism of anti-HLA anti body-induced apoptosis which might have clinical implications. (C) American Society for Histocompatibility and Immunogenetics, 2004. Published by Elsevier Inc.
引用
收藏
页码:189 / 199
页数:11
相关论文
共 31 条
[1]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[2]   Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization [J].
Bossy-Wetzel, E ;
Newmeyer, DD ;
Green, DR .
EMBO JOURNAL, 1998, 17 (01) :37-49
[3]  
BROWN DG, 1993, J BIOL CHEM, V268, P3037
[4]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[5]   Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies [J].
Daniel, D ;
Opelz, G ;
Mulder, A ;
Susal, C .
TRANSPLANTATION, 2003, 75 (08) :1380-1386
[6]   Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis [J].
Daugas, E ;
Susin, SA ;
Zamzami, N ;
Ferri, KF ;
Irinopoulou, T ;
Larochette, N ;
Prévost, MC ;
Leber, B ;
Andrews, D ;
Penninger, J ;
Kroemer, G .
FASEB JOURNAL, 2000, 14 (05) :729-739
[7]  
Drénou B, 1999, J IMMUNOL, V163, P4115
[8]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[9]   Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex:: Role of mitochondria and caspases [J].
Ferri, KF ;
Jacotot, E ;
Blanco, J ;
Esté, JA ;
Zamzami, N ;
Susin, SA ;
Xie, ZH ;
Brothers, G ;
Reed, JC ;
Penninger, JM ;
Kroemer, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08) :1081-1092
[10]   Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid [J].
Fulda, S ;
Scaffidi, C ;
Susin, SA ;
Krammer, PH ;
Kroemer, G ;
Peter, ME ;
Debatin, KM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :33942-33948